Immucell Stock Investor Sentiment

ICCC Stock  USD 3.70  0.04  1.07%   
About 67% of ImmuCell's investor base is looking to short. The analysis of overall sentiment of trading ImmuCell stock suggests that many investors are alarmed at this time. The current market sentiment, together with ImmuCell's historical and current headlines, can help investors time the market. In addition, many technical investors use ImmuCell stock news signals to limit their universe of possible portfolio assets.
  
over six months ago at news.google.com         
ImmuCell Shares Pass Above Two Hundred Day Moving Average of 5.01 - Defense World
Google News at Macroaxis
over six months ago at news.google.com         
Acquisition by David Tomsche of tradable shares of ImmuCell at 7.7 subject to Rule 16b-3
Google News at Macroaxis
over six months ago at news.google.com         
ImmuCells investors will be pleased with their respectable 35 percent return over the last five year...
Google News at Macroaxis
over six months ago at www.macroaxis.com         
Acquisition by David Tomsche of 485 shares of ImmuCell at 7.77 subject to Rule 16b-3
Macroaxis News
over six months ago at www.macroaxis.com         
Acquisition by David Tomsche of tradable shares of ImmuCell at 5.53 subject to Rule 16b-3
Macroaxis News
over six months ago at news.google.com         
ImmuCell Stock Price Crosses Above 200-Day Moving Average of 5.02 - Defense World
Google News at Macroaxis
over six months ago at news.google.com         
ImmuCell Stock Passes Above 200 Day Moving Average of 5.03 - Defense World
Google News at Macroaxis
over six months ago at news.google.com         
ImmuCell Stock Price Crosses Above Two Hundred Day Moving Average of 5.03 - Defense World
Google News at Macroaxis
over six months ago at benzinga.com         
ImmuCell Announces Preliminary, Unaudited Sales Results for Q1 2024
benzinga news
over six months ago at seekingalpha.com         
ImmuCell reports preliminary Q1 sales, stock climbs 7
seekingalpha News
over six months ago at globenewswire.com         
ImmuCell Announces Preliminary, Unaudited Sales Resultsfor Q1 2024
Macroaxis News: globenewswire.com
over six months ago at news.google.com         
Leons Furniture Stock Price Passes Above 200-Day Moving Average of 19.62 - Defense World
Google News at Macroaxis
over six months ago at seekingalpha.com         
ImmuCell files for 20M mixed shelf offering
seekingalpha News
over six months ago at news.google.com         
Theres No Escaping ImmuCell Corporations Muted Revenues - Yahoo Lifestyle UK
Google News at Macroaxis
over six months ago at news.google.com         
ImmuCell Stock Price Crosses Above Two Hundred Day Moving Average of 5.02 - Defense World
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about ImmuCell that are available to investors today. That information is available publicly through ImmuCell media outlets and privately through word of mouth or via ImmuCell internal channels. However, regardless of the origin, that massive amount of ImmuCell data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of ImmuCell news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of ImmuCell relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to ImmuCell's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive ImmuCell alpha.

ImmuCell Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for ImmuCell Stock analysis

When running ImmuCell's price analysis, check to measure ImmuCell's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ImmuCell is operating at the current time. Most of ImmuCell's value examination focuses on studying past and present price action to predict the probability of ImmuCell's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ImmuCell's price. Additionally, you may evaluate how the addition of ImmuCell to your portfolios can decrease your overall portfolio volatility.
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Global Correlations
Find global opportunities by holding instruments from different markets
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA